Copyright
©The Author(s) 2021.
World J Clin Cases. Feb 6, 2021; 9(4): 886-897
Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.886
Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.886
Main laboratory finding | Value | Normal range | |||
Day 1 | Day 2 | Day 3 | Day 4 | ||
White blood cell count | 5.0 | 5.6 | 20.5 | 28.3 | (3.5-9.5) × 109/L |
Lymphocyte percentage | 6.6 | 10.1 | 8.9 | 15.6 | 20%-50% |
Neutrophil percentage | 90 | 86.7 | 90.1 | 81 | 40%-75% |
Hemoglobin | 80 | 99 | 112 | 98 | (115-150) g/L |
Platelets | 30 | 32 | 52 | 35 | (125-350) × 109/L |
Prothrombin time | 18.1 | 18.8 | 18.2 | 16.4 | (9-14) s |
International normalized ratio | 1.6 | 1.68 | 1.62 | 1.42 | |
Prothrombin activity | 54.9 | 51.8 | 54.2 | 63 | % |
Activated partial thromboplastin time standardization | 61 | 55.3 | 54.1 | 56.8 | (20-40) s |
Thrombin time | 39.7 | 37.1 | 50.6 | Chyle blood, no test | (14-21) s |
Fibrinogen | 1.37 | 1.0 | 0.77 | Chyle blood, no test | (2-4) g/L |
D-Dimer | 4.88 | 5.96 | (0-0.5) μg/L | ||
Fibrinogen degradation products | 272.9 | 90.6 | (0-5) μg/L | ||
Erythrocyte sedimentation rate | 10 | (0-20) mm/L | |||
C-reactive protein | 121.01 | 111.7 | 104.2 | (0-10) mg/L | |
Hemolytic index | 15 | 15 | 60 | 55 | 0-15 |
Blood lipid index | 2 | 2 | 2 | 225 | 0-2 |
Total protein | 57.1 | 53.5 | 46.8 | 55.7 | (65-85) g/L |
Albumin | 28.8 | 26.3 | 26.3 | 23.2 | (40-55) g/L |
Globin | 28.3 | 27.3 | 26.2 | 24.4 | (20-40) g/L |
Total bilirubin | 35.9 | 42.9 | 49.6 | 62.1 | (0-21) μmol/L |
Conjugated bilirubin | 14.6 | 19.5 | 27.3 | 35.2 | (0-5) μmol/L |
Unconjugated hyperbilirubinemia | 3.5 | 3.5 | 2.6 | 4.2 | (0-19) μmol/L |
Glutamic-pyruvic transaminase | 84.9 | 90.9 | 139.8 | 153.8 | (0-40) U/L |
Aspartate aminotransferase | 295 | 329 | 593 | 589 | (0-40) U/L |
Alkaline phosphatase | 366 | 510 | 508 | 453 | (38-126) U/L |
γ-Glutamyl transpeptidase | 118 | 161 | 185 | 183 | (6-35) U/L |
Cholinesterase | 3584.3 | 3395.1 | 3476.1 | 4351.8 | (4650-12220) U/L |
Lactate dehydrogenase | 5292 | 5616 | 9299 | 8746 | (313-618) U/L |
K+ | 4.9 | 4.57 | 4.42 | 5.3 | (3.6-5) mm/L |
Na+ | 127.8 | 128.9 | 142.6 | 146.2 | (137-145) mm/L |
Cl- | 102 | 103.9 | 111.8 | 106.7 | (98-107) mm/L |
Creatinine | 288.1 | 299.2 | 298.8 | 311.5 | (41-73) μmol/L |
Carbamide | 16.19 | 17.79 | 22.38 | 28.01 | (2.6-7.5) mm/L |
Uric acid | 683 | 706.4 | 487.4 | 510.4 | (155-357) μmol/L |
Hypersensitive troponin | 0.012 | 0.138 | 13 | 52 | (0-0.034) ng/L |
NT-ProBNP | 4120 | 9910 | 35000 | 35000 | (0-125) pg/L |
Myoglobin | 145.7 | 936.4 | (0-110) ng/moL | ||
Procalcitonin | 10.479 | 24.025 | (0-0.05) ng/mL |
- Citation: Han ZB, Wu J, Liu J, Li HM, Guo K, Sun T. Adult-onset Still's disease evolving with multiple organ failure and death: A case report and review of the literature. World J Clin Cases 2021; 9(4): 886-897
- URL: https://www.wjgnet.com/2307-8960/full/v9/i4/886.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i4.886